Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Thoroughbred fracture risk linked to collagen, study finds
This lack of collagen type III is a result of a change in their DNA sequence.

Horses with lower levels of collagen type III are at higher risk.

Researchers from the Royal Veterinary College (RVC) have developed a new genetic risk scoring system, after discovering new factors contributing to thoroughbred horses’ likelihood of fracture .

Their research revealed that thoroughbred horses with lower levels of collagen type III were at higher risk of fractures.

RVC’s research team, led by Dr Debbie Guest, developed a polygenic risk scoring system to measure horses’ disease risk. The system considers a variety of genes to assess the risk, which the team then used to look at the distribution of scores across the UK’s thoroughbred population.

Using this data, the researchers then selected cells from horses at either end of the risk spectrum to study further.

The cells were examined in a laboratory, to establish a cell model and find new genetic factors that may be involved in fracture risk.

The studies revealed that the horses with a higher risk of fracture also had lower levels of collagen type III. Collagen type III is a gene, found in their bone cells, which is required for normal bone formation.

The researchers say that this lack of collagen type III is a result of a change in their DNA sequence, in the region controlling how much collagen III is produced.

Further research will seek to validate the risk-scoring system using another group of horses. Studies will also use this system and cell model to identify any other genes and processes which may contribute to fracture susceptibility.

Dr Guest, project lead and senior research fellow at the RVC, said: “The development of a polygenic risk score for fracture will allow us to identify horses that are at high genetic risk to allow the targeted use of diagnostic imaging and close monitoring of their bone health.

“This study has also demonstrated the power of using cell models to work out what differences exist in bone cells from high and low-risk horses and therefore why some horses are at high risk.

“This is vital to develop new interventions for high-risk horses in the future so that they are less likely to suffer from a catastrophic fracture."

The full study can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.